| Coronavirus RNA proofreading: molecular basis and therapeutic targeting F Robson, KS Khan, TK Le, C Paris, S Demirbag, P Barfuss, P Rocchi, ... Molecular cell 79 (5), 710-727, 2020 | 447 | 2020 |
| Nucleic acid-based technologies targeting coronaviruses TK Le, C Paris, KS Khan, F Robson, WL Ng, P Rocchi Trends in Biochemical Sciences 46 (5), 351-365, 2021 | 47 | 2021 |
| DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancer TK Le, C Cherif, K Omabe, C Paris, F Lannes, S Audebert, E Baudelet, ... Molecular Therapy 31 (2), 471-486, 2023 | 16 | 2023 |
| Menin inhibition suppresses castration-resistant prostate cancer and enhances chemosensitivity C Cherif, DT Nguyen, C Paris, TK Le, T Sefiane, N Carbuccia, P Finetti, ... Oncogene 41 (1), 125-137, 2022 | 12 | 2022 |
| Castration-resistant prostate cancer: from uncovered resistance mechanisms to current treatments TK Le, QH Duong, V Baylot, C Fargette, M Baboudjian, L Colleaux, ... Cancers 15 (20), 5047, 2023 | 6 | 2023 |
| Antisense oligonucleotide-based therapeutic against menin for triple-negative breast cancer treatment DT Nguyen, TK Le, C Paris, C Cherif, S Audebert, S Oluchi Udu-Ituma, ... Biomedicines 9 (7), 795, 2021 | 6 | 2021 |
| Nucleoside-lipid-based nanoparticles for phenazine delivery: a new therapeutic strategy to disrupt Hsp27-eIF4E interaction in castration resistant prostate cancer H Ziouziou, C Paris, S Benizri, TK Le, C Andrieu, DT Nguyen, A Appavoo, ... Pharmaceutics 13 (5), 623, 2021 | 4 | 2021 |
| HSP27/Menin Expression as New Prognostic Serum Biomarkers of Prostate Cancer Aggressiveness Independent of PSA A Bourefis, H Berredjem, O Djeffal, TK Le, S Giusiano, P Rocchi Cancers 14 (19), 4773, 2022 | 2 | 2022 |
| ZNF703 mRNA-Targeting Antisense Oligonucleotide Blocks Cell Proliferation and Induces Apoptosis in Breast Cancer Cell Lines S Udu-Ituma, J Adélaïde, TK Le, K Omabe, P Finetti, C Paris, A Guille, ... Pharmaceutics 15 (7), 1930, 2023 | 1 | 2023 |
| Between hope and reality: treatment of genetic diseases through nucleic acid-based drugs V Baylot, TK Le, D Taïeb, P Rocchi, L Colleaux Communications Biology 7 (1), 489, 2024 | | 2024 |
| Creating overview and summary figures M Critcher, LAG da Silva, D Dormann, ZT Campbell, TK Le, P Rocchi, ... Trends in Biochemical Sciences 48 (2), 97-99, 2023 | | 2023 |
| Translationally Controlled Tumor Protein: A Key Target to Abrogate DNA Repair and Therapeutic Resistance in Cancer PR Kenneth Omabe, Thi Khanh Le, Jerry Ombor, Clement Paris, David Taïeb J Cancer Res Therap Oncol 10: 1-17, 10.17303/jcrto.2022.10.101, 2022 | | 2022 |
| DDX5, an Hsp27-interacting protein, promotes therapeutic resistance of prostate cancer through activating the DNA damage response TK Le Aix-Marseille, 2021 | | 2021 |
palma rocchimarseille or wuhan or vancouver or triesteBestätigte E-Mail-Adresse bei inserm.fr
